These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 8430627

  • 1. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the electrophysiologic effects of intravenous and oral verapamil in patients with paroxysmal supraventricular tachycardia.
    Klein GJ, Gulamhusein S, Prystowsky EN, Carruthers SG, Donner AP, Ko PT.
    Am J Cardiol; 1982 Jan 15; 49(1):117-24. PubMed ID: 7053599
    [Abstract] [Full Text] [Related]

  • 3. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 4. Acute and chronic effects of verapamil in patients with paroxysmal supraventricular tachycardia.
    Sakurai M, Yasuda H, Kato N, Nomura A, Fujita M, Nishino T, Fujita K, Koike Y, Saito H.
    Am Heart J; 1983 Apr 01; 105(4):619-28. PubMed ID: 6837416
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S, Klein GJ, Kowey PR, Calvo RA, Boccadamo R, Brown JE, Sharma AD, Gadhoke A, Olukotun AY.
    Am J Cardiol; 1987 Feb 01; 59(4):307-12. PubMed ID: 3812280
    [Abstract] [Full Text] [Related]

  • 7. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 8. Effects of oral verapamil in patients with atrioventricular reentrant tachycardia incorporating an accessory pathway.
    Wu D, Kou HC, Yeh SJ, Lin FC, Hung JS.
    Circulation; 1983 Feb 01; 67(2):426-33. PubMed ID: 6848233
    [Abstract] [Full Text] [Related]

  • 9. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group.
    Dougherty AH, Jackman WM, Naccarelli GV, Friday KJ, Dias VC.
    Am J Cardiol; 1992 Sep 01; 70(6):587-92. PubMed ID: 1510006
    [Abstract] [Full Text] [Related]

  • 10. Comparative clinical and electrophysiologic effects of adenosine triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia.
    Belhassen B, Glick A, Laniado S.
    Circulation; 1988 Apr 01; 77(4):795-805. PubMed ID: 3349581
    [Abstract] [Full Text] [Related]

  • 11. Clinical and electrophysiologic effects of magnesium sulfate on paroxysmal supraventricular tachycardia and comparison with adenosine triphosphate.
    Viskin S, Belhassen B, Sheps D, Laniado S.
    Am J Cardiol; 1992 Oct 01; 70(9):879-85. PubMed ID: 1529941
    [Abstract] [Full Text] [Related]

  • 12. Nadolol and supraventricular tachycardia: an electrophysiologic study.
    Chang MS, Sung RJ, Tai TY, Lin SL, Liu PH, Chiang BN.
    J Am Coll Cardiol; 1983 Nov 01; 2(5):894-903. PubMed ID: 6138376
    [Abstract] [Full Text] [Related]

  • 13. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT, Campbell RW, McComb JM.
    J Cardiovasc Pharmacol; 1991 Feb 01; 17(2):310-5. PubMed ID: 1709237
    [Abstract] [Full Text] [Related]

  • 14. Effect of verapamil on retrograde conduction in atrioventricular nodal reentrant tachycardia.
    Reddy CP, McAllister RG.
    Am J Cardiol; 1984 Sep 01; 54(6):535-43. PubMed ID: 6475770
    [Abstract] [Full Text] [Related]

  • 15. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 16. [Electrophysiologic effects of betaxolol on conduction properties of the antegrade and retrograde pathway in patients with typical atrioventricular node reentry tachycardia following intravenous and oral administration].
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Z Kardiol; 1988 Aug 01; 77(8):527-33. PubMed ID: 3176596
    [Abstract] [Full Text] [Related]

  • 17. Effects of verapamil on supraventricular tachycardia in patients with overt and concealed Wolff-Parkinson-White syndrome.
    Hamer A, Peter T, Platt M, Mandel WJ.
    Am Heart J; 1981 May 01; 101(5):600-12. PubMed ID: 7223599
    [Abstract] [Full Text] [Related]

  • 18. Combined verapamil and propranolol for supraventricular tachycardia.
    Yee R, Gulamhusein SS, Klein GJ.
    Am J Cardiol; 1984 Mar 01; 53(6):757-63. PubMed ID: 6702624
    [Abstract] [Full Text] [Related]

  • 19. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 20. Ethmozin. II. Effects of intravenous drug administration on atrioventricular nodal reentrant tachycardia.
    Chazov EI, Rosenshtraukh LV, Shugushev KK.
    Am Heart J; 1984 Sep 01; 108(3 Pt 1):483-9. PubMed ID: 6382989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.